Los Angeles Capital Management LLC Arvinas, Inc. Transaction History

Los Angeles Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$24.46 - $40.4 $35,711 - $58,984	-1,460 Reduced 4.89%	28,422 $756,000
Q1 2024 Apr 05, 2024	BUY	$36.38 - $52.31 $72,505 - $104,253	1,993 Added 7.15%	29,882 $1.23 Million
Q4 2023 Feb 06, 2024	BUY	$14.19 - $42.33 $395,744 - $1.18 Million	27,889 New	27,889 $1.15 Million
Q4 2022 Feb 06, 2023	SELL	$32.47 - $57.24 $22,371 - $39,438	-689 Reduced 7.71%	8,243 $281,000
Q3 2022 Nov 02, 2022	BUY	$41.87 - $57.99 $61,507 - $85,187	1,469 Added 19.68%	8,932 $397,000
Q2 2022 Aug 05, 2022	SELL	$36.01 - $74.24 $70,399 - $145,139	-1,955 Reduced 20.76%	7,463 $314,000
Q1 2022 May 06, 2022	SELL	$60.27 - $81.57 $10,908 - $14,764	-181 Reduced 1.89%	9,418 $634,000
Q4 2021 Feb 03, 2022	SELL	$65.85 - $96.21 $5,663 - $8,274	-86 Reduced 0.89%	9,599 $788,000
Q3 2021 Nov 08, 2021	BUY	$73.2 - $107.87 $73,566 - $108,409	1,005 Added 11.58%	9,685 $796,000
Q2 2021 Aug 05, 2021	SELL	$60.45 - $84.26 $208,310 - $290,359	-3,446 Reduced 28.42%	8,680 $668,000
Q1 2021 May 05, 2021	SELL	$58.19 - $91.37 $1 Million - $1.57 Million	-17,225 Reduced 58.69%	12,126 $801,000
Q4 2020 Feb 04, 2021	SELL	$20.19 - $84.93 $57,137 - $240,351	-2,830 Reduced 8.79%	29,351 $2.49 Million
Q3 2020 Nov 02, 2020	BUY	$22.99 - $36.34 $360,828 - $570,356	15,695 Added 95.2%	32,181 $760,000
Q2 2020 Aug 05, 2020	BUY	$29.88 - $56.74 $492,601 - $935,415	16,486 New	16,486 $552,000

224

70.9M

1.52M

346K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $986M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.